NMDA receptors are expressed by small-cell lung cancer and are potential targets for effective treatment.

However, MK-801 in these same doses produced highly significant ( P < 0.001) reductions in the rate of tumor growth, to almost 60% that of controls, over the course of the study ( Figure 5b ).

also in 132,142 other papers